Meta Pixel

News and Announcements

Prescient Therapeutics Share Purchase Plan Results

  • Published November 18, 2015 3:48PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

18th November 2015, ASX Announcement

Cancer drug development Prescient Therapeutics Limited (ASX: PTX) has closed its Share Purchase Plan, with strong demand from existing and new investors.

Investors have subscribed for $1,201,500 in new shares, with the price per share to be based on a 20% discount to the 5 day volume weighted average price (VWAP) before the issue date of 23 November 2015.

A final price will be announced on the date of issue of the SPP shares.

PTX advises that the Company is only permitted to accept a maximum of 30% of its current issued capital. In the event that a scale back is required, applications are new shares will be scaled back proportionately

To read the full announcement, please click here.  

Capital Insights
Where’s the beef? Blackstone just answered the AI question.

In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]

Company Updates
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation

For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]

Join over 45,000+ sophisticated investors

Join Now